Incyte Corp. (NASDAQ: INCY) is our next pick from the single-digit sect, and it's not a play for the squeamish. The company is part of the frequently volatile biotechnology industry, and focuses its efforts on drugs that inhibit specific enzymes thought to cause cancer, diabetes, and other serious maladies. After abandoning its DFC medication, designed to help patients with HIV, the company has focused its efforts on a number of other treatments in the pipeline. A successful clinical trial could result in impressive gains in the stock, while another disappointment could send the shares unraveling. But for now, the stock looks like a nice potential play for an aggressive trader. The stock has been in rally mode since early August, aside from a slight pullback that petered out a few weeks ago. From early August through mid-November, INCY shares had increased more than 80% and toppled several layers of technical resistance.
Currently, the stock is consolidating some of its recent gains as it tests its 10-week moving average. This trendline coincides with chart support at the $8.00 mark, representing the equity's April 27 peak. This level served as resistance seven months ago but may reverse roles and act as support this time around, especially as its presence is bolstered by the 10-week trendline.
INCY has also shown remarkable relative strength when matched against both the S&P 500 Index and its peers in the biotech sector. Strong price action as compared to broader indices is also a positive technical sign, particularly for the short term.
Like several of the names on this list, INCY has been a popular choice among the short sellers. In fact, almost 13% of the stock's available float is devoted to the short side. It would take about 12 trading days currently -- at the stock's average daily volume -- to dump all of these shorted positions. Should INCY continue to hold the support of its 10-week moving averages, the bears could move toward the exits, catalyzing a short-covering rally.
10 stocks under $10: Bruker BioSciences (BRKR)
10 stocks under $10: TriQuint Semiconductor (TQNT)
10 stocks under $10: CBIZ Inc. (CBZ)
10 stocks under $10: Brigham Exploration (BEXP)
10 Stocks Under $10: Medical Staffing Network Holdings (MRN)
Beth Gaston Moon is an analyst at Schaeffer's Investment Research.
Entrepreneur's Journal: Putting together a solid sales contract
The week in preview: Earnings from Walmart, Macy's, and other retailers
Six top trades for the rest of 2009
Reader Comments (Page 1 of 1)
11-29-2007 @ 8:55AM
Chris Laster said...
How can I purchase some of this stock as a first time stock investor?
11-29-2007 @ 10:32AM
Sue said...
I am interested in purchasing some of these stocks. Please advise me who to contact or how to make purchases.
11-29-2007 @ 4:49PM
juan said...
You can open an account with Ameritrade, e-trade or any other in the online investing group or get in contact with a stock broker in your area, it's that easy. Sue Have you heard about himalayan goji juice, if not you're not alone. Himalayan goji juice is the hottest nutrition item in USA today. I joined this company 8 months ago and I'm very happy with the money I am generating so far. If you or any one you know are looking to start tour own business, become financially free and be able to help others, you need to take a look at it. Please go to my site and see for yourself.
http://www.healthcounts.freelife.com, click on the USA map to get in. Then go to: http://gojihealthstories.com (public web) to see why many Americans and people all over the world are drinking himalayan goji juice. In my short time in the business I've have very good success and would like to share this with as many people as I can. My telephoe number is in the web site in case you want to call me. As far as buying stocks, do your research before you jump into it. Buying stocks can be very rewrading but you can loose your shirt if you don't have enough experience. I lost a substantial amount of money when I first started. Please do your research before buying.
At your service,
Juan R
juanrodz7@aol.com